CD86 and Granuloma: An intense staining for CD4, CD8, and CD86 molecules was observed in NAC-treated granulomas suggesting that reduction in the extent of necrosis and ROI production will maintain the viability of myeloid and lymphoid cells in the granulomas (2L, N, P, R, T).